WVXU: UC public health nursing expert sheds light on xylazine’s community impact
An animal tranquilizer, xylazine, has been increasingly found in illicit drugs and detected in overdose deaths across the country, sounding alarm bells at the local and federal levels. Tasha Turner-Bicknell, DNP, University of Cincinnati professor and public health nursing online programs director, served as a guest on WVXU's Cincinnati Edition to discuss the impacts and risks of xylazine.
Tasha Turner-Bicknell
Although not an opioid, xylazine can depress breathing, blood pressure, heart rate and body temperature to critical levels. And, because it is not an opioid, reversing an overdose caused by xylazine with naloxone can be more difficult; rescue breathing as part of CPR is needed, but people who use drugs often are wary of calling first responders, despite Good Samaritan laws in place.
"It is still hard to test for xylazine's presence in the body since the substance is not intended for human use. This makes it difficult to estimate how many overdose deaths can be attributed to xylazine," Turner-Bicknell said. "So, in the early days, people thought xylazine wasn’t present in their community."
Additionally, people who inject drugs containing xylazine can develop severe skin wounds and patches of dead tissue that easily become infected and, if left untreated, may lead to amputation. These wounds can develop in areas of the body away from the injection site and may become life-threatening.
"Providing basic medical care to people who use drugs is essential, or else these wounds will become worse and people will end up in the emergency room," Turner-Bicknell said. "And we know that the emergency room is not the ideal place for wound treatment."
Turner-Bicknell (left) in WVXU's studios as a guest on Cincinnati Edition.
As test strips for xylazine detection haven’t been approved for mass distribution and lawmakers work through the long process of classifying xylazine as a narcotic, the inclusion of wound care to avoid infections and more serious consequences in harm reduction outreach services is a step in the right direction.
And, while safe injection sites — which provide people who use drugs with a safe environment with access to health care and education — are an important factor in harm reduction, we will never have enough to be available for everyone, Turner-Bicknell said.
As a public health nurse, Turner-Bicknell has championed these kinds of harm reduction efforts. Her latest work focuses on increasing the implementation of harm reduction vending machines, providing safer smoking kits and developing mobile units as ways to extend community outreach to individuals previously not captured by existing harm reduction services, including people who smoke drugs, use stimulants or are unable or unwilling to attend syringe service programing.
Turner-Bicknell was selected present on this work at the 27th annual Harm Reduction International Conference, April 16-19 in Melbourne, Australia.
Listen to an audio recording of the March 27 Cincinnati Edition program at wvxu.org.
Learn More about UC's Public Health Nursing Online Programs
UC College of Nursing's Public Health Nursing online programs prepare you to respond to public health events with research-backed, population-based interventions and to lead and advance public health initiatives.
Learn more:
Related Stories
University of Cincinnati gets $1.1M for AI physician training
January 30, 2026
The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.
Hoxworth Blood Center teams up with Cyclones in February for biggest blood drive event of year
January 30, 2026
Hoxworth Blood Center, University of Cincinnati, is teaming up with the Cyclones and other local businesses to host its annual Queen City Blood Drive on Feb. 9-11 at Heritage Bank Center. If you can’t attend this event, Hoxworth encourages you to still make donating a #HoxworthHabit and give blood this February.
Research findings may lead to new test for endometriosis
January 30, 2026
Endometriosis affects one in 10 women worldwide, and many go years before diagnosis. Symptoms include chronic pelvic pain, heavy bleeding during menstruation and/or sexual intercourse, bloating and fatigue. Katie Burns’ research at the University of Cincinnati is focused on creating a new, non-invasive test for endometriosis, using white blood cells as biomarkers. Burns, PhD, is an associate professor in the Department of Environmental and Public Health Sciences in the College of Medicine.